Published in J Infect Dis on May 01, 1993
Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion. Infect Immun (1994) 3.06
Utilization of similar mechanisms by Legionella pneumophila to parasitize two evolutionarily distant host cells, mammalian macrophages and protozoa. Infect Immun (1997) 2.29
Expression of multiple pili by Legionella pneumophila: identification and characterization of a type IV pilin gene and its role in adherence to mammalian and protozoan cells. Infect Immun (1998) 1.94
Natural competence for DNA transformation by Legionella pneumophila and its association with expression of type IV pili. J Bacteriol (1999) 1.92
Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model. Proc Natl Acad Sci U S A (1999) 1.65
Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect Immun (1996) 1.57
Identification and temperature regulation of Legionella pneumophila genes involved in type IV pilus biogenesis and type II protein secretion. Infect Immun (1998) 1.51
Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model. Infect Immun (1998) 1.50
Legionella pneumophila type II protein secretion promotes virulence in the A/J mouse model of Legionnaires' disease pneumonia. Infect Immun (2004) 1.46
Apoptosis in macrophages and alveolar epithelial cells during early stages of infection by Legionella pneumophila and its role in cytopathogenicity. Infect Immun (1999) 1.45
Induced expression of the Legionella pneumophila gene encoding a 20-kilodalton protein during intracellular infection. Infect Immun (1998) 1.39
Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transduction. Respir Res (2006) 1.39
Identification of a Gal/GalNAc lectin in the protozoan Hartmannella vermiformis as a potential receptor for attachment and invasion by the Legionnaires' disease bacterium. J Exp Med (1997) 1.28
Heterogeneity in the attachment and uptake mechanisms of the Legionnaires' disease bacterium, Legionella pneumophila, by protozoan hosts. Appl Environ Microbiol (1998) 1.15
Discovery of a nonclassical siderophore, legiobactin, produced by strains of Legionella pneumophila. J Bacteriol (2000) 1.07
Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila. J Exp Med (1998) 0.96
Purification of Legiobactin and importance of this siderophore in lung infection by Legionella pneumophila. Infect Immun (2009) 0.90
Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion. Infect Immun (2014) 0.90
Viable but not culturable forms of Legionella pneumophila generated after heat shock treatment are infectious for macrophage-like and alveolar epithelial cells after resuscitation on Acanthamoeba polyphaga. Microb Ecol (2014) 0.89
Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila. Infect Immun (2005) 0.88
Essential role for the Legionella pneumophila rep helicase homologue in intracellular infection of mammalian cells. Infect Immun (2000) 0.87
Lcl of Legionella pneumophila is an immunogenic GAG binding adhesin that promotes interactions with lung epithelial cells and plays a crucial role in biofilm formation. Infect Immun (2011) 0.86
Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells. BMC Microbiol (2007) 0.85
Invasion of eukaryotic cells by Legionella pneumophila: A common strategy for all hosts? Can J Infect Dis (1997) 0.85
Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. Infect Immun (2013) 0.84
Staying in Shape: the Impact of Cell Shape on Bacterial Survival in Diverse Environments. Microbiol Mol Biol Rev (2016) 0.82
Infection of cultured human endothelial cells by Legionella pneumophila. PLoS One (2008) 0.81
Hyperoxia accelerates Fas-mediated signaling and apoptosis in the lungs of Legionella pneumophila pneumonia. BMC Res Notes (2011) 0.78
PilY1 Promotes Legionella pneumophila Infection of Human Lung Tissue Explants and Contributes to Bacterial Adhesion, Host Cell Invasion, and Twitching Motility. Front Cell Infect Microbiol (2017) 0.75
Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon. Mol Microbiol (1991) 6.44
An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A (1985) 6.00
Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. Science (1981) 5.95
Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest (1990) 5.21
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol (1980) 4.00
A new procedure for purifying histone pairs H2A + H2B and H3 + H4 from chromatin using hydroxylapatite. Nucleic Acids Res (1979) 3.62
DNA sequence of mip, a Legionella pneumophila gene associated with macrophage infectivity. Infect Immun (1989) 3.29
A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect Immun (1989) 3.18
Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest (1996) 2.97
Phenotypic modulation by Legionella pneumophila upon infection of macrophages. Infect Immun (1993) 2.79
Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med (1997) 2.68
Genetic analysis of the phase variation control of expression of type 1 fimbriae in Escherichia coli. J Bacteriol (1985) 2.62
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun (1997) 2.54
Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers. Br J Vener Dis (1984) 2.50
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther (1993) 2.48
Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol (1991) 2.47
Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media. J Bacteriol (1993) 2.44
CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection. J Immunol (2000) 2.43
Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med (1998) 2.43
Growth of Legionella pneumophila in a human macrophage-like (U937) cell line. Microb Pathog (1988) 2.38
Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol (2001) 2.38
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol (1995) 2.37
Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med (2001) 2.35
Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J Immunol (1990) 2.28
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest (2000) 2.26
Conjugal transfer of the gonococcal penicillinase plasmid. Science (1977) 2.22
Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.20
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
Antigenic quantitation of type 1 fimbriae on the surface of Escherichia coli cells by an enzyme-linked immunosorbent inhibition assay. Infect Immun (1982) 2.19
Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol (1991) 2.17
Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistance. Antimicrob Agents Chemother (1974) 2.13
Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol (1996) 2.12
Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10
Penicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infection. Infect Immun (1977) 2.09
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Cloning and expression of Legionella pneumophila antigens in Escherichia coli. Infect Immun (1984) 2.03
A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J Infect Dis (1990) 2.01
Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci U S A (1998) 1.98
Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals. J Biol Chem (1981) 1.88
Identification of mip-like genes in the genus Legionella. Infect Immun (1990) 1.87
Mutations to increased antibiotic sensitivity in naturally-occurring gonococci. Nature (1978) 1.83
"Campylobacter cinaedi" bacteremia: case report and laboratory findings. J Clin Microbiol (1987) 1.83
The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol (1984) 1.81
Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol (1995) 1.80
Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groups. Can J Microbiol (1975) 1.79
Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J Bacteriol (1993) 1.78
Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells. J Lab Clin Med (1998) 1.76
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun (2001) 1.76
Pseudocatabolite repression of type 1 fimbriae of Escherichia coli. J Bacteriol (1982) 1.69
Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol (1999) 1.69
The impact of new cloning techniques on the diagnosis and treatment of infectious diseases. N Engl J Med (1984) 1.68
Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67
Genetic mapping and transcriptional orientation of the fimD gene. J Bacteriol (1983) 1.66
Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J Bacteriol (1991) 1.61
The relationship of inoculum size to lung bacterial clearance and phagocytic cell response in mice. Am Rev Respir Dis (1979) 1.61
Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies. J Bacteriol (1984) 1.59
Human tissue research in the genomic era of medicine: balancing individual and societal interests. Arch Intern Med (2000) 1.59
GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J Immunol (2000) 1.58
Isolation and characterization of a monoclonal antibody directed against type 1 fimbriae organelles from Escherichia coli. Infect Immun (1983) 1.57
Genetics and molecular pathogenesis of Legionella pneumophila, an intracellular parasite of macrophages. Mol Biol Med (1989) 1.53
Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol (1995) 1.53
The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol (2000) 1.51
Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacterium species). J Neurosurg (1976) 1.51
Influence of sublethal concentrations of antibiotics on the expression of the mannose-specific ligand of Escherichia coli. Infect Immun (1980) 1.49
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49
The role of methotrexate in the management of steroid-dependent asthma. Chest (1994) 1.46
Expanding the frontiers of lung biology through the creative use of alveolar epithelial cells in culture. Am J Physiol (1996) 1.46
Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med (2000) 1.46
Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol (1991) 1.45
Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J Clin Invest (1996) 1.45
Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. J Clin Invest (1987) 1.45
The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol (2000) 1.39
Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol (1984) 1.39
Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J Immunol (1997) 1.39
Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. J Invest Dermatol (1980) 1.39
Corneal allografts fail to express Ia antigens. Nature (1979) 1.38
Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum Gene Ther (1995) 1.38
Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): I. Bacteriology, epidemiology, host factors, pathogen factors, and pathology. Semin Arthritis Rheum (1981) 1.38
Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab Invest (1994) 1.37
Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol (1994) 1.36
Operon fusion of the phase variation switch. A virulence factor in Escherichia coli. Infection (1982) 1.35
Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am J Pathol (1987) 1.34
Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet (1986) 1.34
Immunoelectron microscopic analysis of elongation of type 1 fimbriae in Escherichia coli. J Bacteriol (1987) 1.34
Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol (2001) 1.33
Nucleosome structure, DNA folding, and gene activity. Cold Spring Harb Symp Quant Biol (1978) 1.32
Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection. J Immunol (1991) 1.32
Further analysis of the role of calcium in rotavirus morphogenesis. Virology (1987) 1.32
Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun (1991) 1.30
Inversion-independent phase variation of type 1 fimbriae in Escherichia coli. J Bacteriol (1993) 1.30
Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther (1999) 1.29
Inhibitory activity of sinefungin and SIBA (5'-deoxy-5'-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of Leishmania. FEBS Lett (1980) 1.28